Genetic analysis revealed the de novo heterozygous missense variant p.Arg716Cys in the SEC23A gene and so this is the first reported case of AD-CLSD presenting specific neurological manifestations never described before. The gene discussed is SEC23A; the disease is Alzheimer disease.